Regulation of Population Genomics Projects in China

1. Introduction

Population genomics is the study of genetic variations across large groups of people to understand human evolution, disease susceptibility, migration, ancestry, and population diversity. In China, population genomics research is regulated through a combination of human genetic resources legislation, personal information protection rules, biosecurity requirements, ethical review standards, and scientific research regulations.

China considers human genetic resources (HGR) strategically important because they contain information relevant to public health, biomedical innovation, national security, and population diversity. Consequently, large-scale genomic projects involving Chinese citizens may face special requirements concerning sample collection, international collaboration, data storage, access, and cross-border transfers.

The principal legislation is the Regulation on the Administration of Human Genetic Resources (2019), subsequently amended in 2024, together with the Biosecurity Law (2021), the Personal Information Protection Law (PIPL, 2021), and the Data Security Law (2021).

2. Legal Framework Governing Population Genomics

A. Regulation on Human Genetic Resources

China's HGR framework is the central legal regime for population genomics. It covers human genetic materials, such as blood, tissue and other biological samples, as well as information derived from those materials.

The principal rules include:

State oversight: Human genetic resources are subject to state regulation, particularly where research involves significant population datasets or international collaboration.

Collection and preservation: Collection and preservation activities must satisfy applicable eligibility, approval, filing, ethical review, and technical requirements.

International collaboration: Foreign organizations and foreign-controlled entities may face restrictions and additional procedures when conducting research using Chinese human genetic resources.

Information security: International provision or export of human genetic resource information may require security review, filing, or other compliance procedures, depending on the circumstances.

Since 2024, administration of human genetic resources has been transferred from the Ministry of Science and Technology to the National Health Commission under the revised regulatory arrangements.

B. Biosecurity Law 2021

The Biosecurity Law establishes a broader framework for protecting biological resources, public health, and national security. Population genomics projects may fall within its scope when they implicate human genetic resources, biotechnology risks, or national biosecurity interests.

Researchers and institutions must consider whether their activities create biological security risks, whether appropriate risk assessments are required, and whether applicable reporting and supervision obligations are triggered.

C. Personal Information Protection Law 2021

Genomic information can identify an individual or reveal sensitive information about their health and biological characteristics. Under PIPL, personal information relating to medical health is sensitive personal information.

Processing such information generally requires a specific purpose, sufficient necessity, strict protective measures, and separate consent where required by law. Cross-border transfers must also comply with applicable data-export requirements. Consent alone does not replace approvals or other obligations under China's human genetic resources regime.

3. Ethical Approval and Informed Consent

Population genomics projects frequently involve collecting samples from thousands or millions of participants. Ethical review is therefore essential, particularly where research includes vulnerable groups, sensitive health information, or genetic characteristics associated with particular ethnic communities.

Under China's applicable biomedical research ethics rules, institutions must obtain ethics review where required and ensure that consent procedures are appropriate to the proposed research. Participants should be informed about the purpose of the study, the nature of sample collection, potential risks, data use, and relevant sharing arrangements.

Researchers must also consider whether subsequent use of samples or data falls within the scope of the original consent. Consent to participate does not automatically authorize every future research use or international transfer.

4. Foreign Collaboration and Cross-Border Data Transfers

International population genomics projects require particular care. Foreign organizations generally cannot independently collect or preserve Chinese human genetic resources without satisfying the applicable Chinese regulatory requirements.

Joint scientific research may be permitted under the relevant cooperation framework, subject to applicable approvals or filings, institutional participation requirements, and protections for Chinese collaborators. Transfers of human genetic resource information abroad may also trigger security review or other regulatory procedures.

In addition, PIPL and the Data Security Law may impose separate requirements concerning personal information, important data, and cross-border transfers. Researchers must assess the applicable legal regimes independently rather than assume that compliance with one automatically satisfies the others.

5. Important Cases and Enforcement Examples

Chinese judicial decisions specifically addressing large-scale population genomics remain limited. Nevertheless, several cases illustrate the legal principles relevant to genomic research.

A. He Jiankui Case (2019)

In December 2019, the Shenzhen Nanshan District People's Court convicted scientist He Jiankui and two collaborators for illegally conducting human embryo gene-editing activities. He received a sentence of three years' imprisonment and a fine of RMB 3 million.

The research involved editing the CCR5 gene in human embryos, resulting in the birth of gene-edited children. The court found that the defendants had acted unlawfully in pursuing reproductive gene-editing research.

Legal significance: Although this was not a population genomics case, it demonstrates that scientific research involving human genetic material is subject to legal and ethical constraints. Institutional approval, informed consent, and scientific ambition do not excuse violations of mandatory rules.

B. Xu Ting and Related Human Genetic Resources Enforcement Context

China's human genetic resources regulatory framework has been applied to research involving foreign collaborators and access to Chinese genetic materials. However, it is important not to confuse administrative enforcement announcements with judicial precedents: not every publicly reported regulatory violation resulted in a court judgment.

For academic analysis, the relevant principle is that unauthorized collection, preservation, international collaboration, or provision of genetic information can lead to administrative consequences under the applicable HGR rules. A specific reported enforcement action should be cited by its official notice, date, and responsible authority rather than attributed to a court without verification.

C. No Established Population-Genomics-Specific Leading Judgment

There is no widely established leading Chinese judicial precedent that comprehensively determines the legality of a national population genomics project under the complete HGR, PIPL, and Data Security Law framework. Accordingly, the most reliable analysis combines the governing legislation with relevant biotechnology cases and documented administrative enforcement.

6. Penalties and Compliance Responsibilities

Violations may lead to suspension of research, confiscation of unlawful gains, fines, restrictions on research activities, or other administrative sanctions. Serious violations may also create civil or criminal liability where the applicable legal elements are satisfied.

Institutions should maintain a compliance process covering ethics review, consent documentation, sample provenance, access controls, data minimization, collaboration agreements, and cross-border transfer assessments.

7. Conclusion

China regulates population genomics through a multilayered system designed to protect participants, safeguard human genetic resources, and maintain national biosecurity. The key legislation includes the HGR Regulation, Biosecurity Law, PIPL, and Data Security Law. The He Jiankui case illustrates the consequences of unlawful human genetic research, while the limited number of directly relevant population-genomics judgments highlights the importance of distinguishing binding legal rules from broader enforcement examples.

For researchers, the central requirement is to establish lawful authority for every stage of a project—from sample collection and consent to data analysis, international collaboration, and publication—before research begins.